Australia's Sigma Unlikely To Be Saved By iNova Investors
This article was originally published in PharmAsia News
Executive Summary
Reports predicting Australia's financially troubled Sigma Pharmaceuticals might be bought and saved are being dashed by closer looks at possible suitors